Concepedia

Publication | Open Access

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo

DOIFull Paper Access

421

Citations

23

References

2020

Year

Alexander M.M. Eggermont, Michal Kiciński, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Adnan Khattak, Matteo S. Carlino,
JAMA Oncology

Abstract

ClinicalTrials.gov identifier: NCT02362594; EudraCT identifier: 2014-004944-37.

References

YearCitations

Page 1